(Q39102547)

9 September 2017

title

Alteration of cancer stem cell-like phenotype by histone deacetylase inhibitors in squamous cell carcinoma of the head and neck (English)

1 reference

9 September 2017

0 references

neoplastic stem cells

1 reference

based on heuristic

inferred from title

squamous cell carcinoma

1 reference

1 reference

Kazuaki Chikamatsu

1

1 reference

9 September 2017

Hiroki Ishii

2

1 reference

9 September 2017

Takaaki Murata

3

1 reference

9 September 2017

Koichi Sakakura

4

1 reference

9 September 2017

Masato Shino

5

1 reference

9 September 2017

Minoru Toyoda

6

1 reference

9 September 2017

Katsumasa Takahashi

7

1 reference

9 September 2017

Keisuke Masuyama

8

1 reference

9 September 2017

publication date

1 October 2013

1 reference

9 September 2017

1 reference

9 September 2017

volume

104

1 reference

9 September 2017

issue

11

1 reference

9 September 2017

page(s)

1468-1475

1 reference

describes a project that uses

9 September 2017

HSC-2

0 references

KUMA-1

0 references

cites work

The cancer stem cell: premises, promises and challenges

1 reference

The cancer stem cell hypothesis: in search of definitions, markers, and relevance

21 January 2018

1 reference

Heterogeneity in cancer: cancer stem cells versus clonal evolution

21 January 2018

1 reference

Prospective identification of tumorigenic breast cancer cells

21 January 2018

1 reference

Prospective identification of tumorigenic prostate cancer stem cells

21 January 2018

1 reference

Identification of pancreatic cancer stem cells

21 January 2018

1 reference

Identification of cells initiating human melanomas

21 January 2018

1 reference

Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma

21 January 2018

1 reference

CD133, one of the markers of cancer stem cells in Hep-2 cell line

21 January 2018

1 reference

Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer.

21 January 2018

1 reference

Cancer stem cells in head and neck squamous cell cancer

21 January 2018

1 reference

Development and characterization of gemcitabine-resistant pancreatic tumor cells.

21 January 2018

1 reference

Tumorigenesis of chemotherapeutic drug-resistant cancer stem-like cells in brain glioma

21 January 2018

1 reference

Colorectal cancer stem cells are enriched in xenogeneic tumors following chemotherapy

21 January 2018

1 reference

Cancer epigenetics reaches mainstream oncology

21 January 2018

1 reference

21 January 2018

Epigenetics in cancer

1 reference

Histone deacetylase inhibitors in cancer therapy

21 January 2018

1 reference

Histone deacetylase inhibitors: Potential in cancer therapy

21 January 2018

1 reference

Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain

21 January 2018

1 reference

Duration of nuclear NF-kappaB action regulated by reversible acetylation

21 January 2018

1 reference

Stat3 dimerization regulated by reversible acetylation of a single lysine residue

21 January 2018

1 reference

Expansion and characterization of cancer stem-like cells in squamous cell carcinoma of the head and neck

21 January 2018

1 reference

Identification and expansion of human colon-cancer-initiating cells

21 January 2018

1 reference

Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines

21 January 2018

1 reference

Resistance to apoptosis-inducing stimuli in CD44+ head and neck squamous cell carcinoma cells

21 January 2018

1 reference

CD44-positive cells are responsible for gemcitabine resistance in pancreatic cancer cells.

21 January 2018

1 reference

Promotion of neurite and filopodium formation by CD47: roles of integrins, Rac, and Cdc42.

21 January 2018

1 reference

Modified fixed-ratio isobologram method for studying in vitro interactions between atovaquone and proguanil or dihydroartemisinin against drug-resistant strains of Plasmodium falciparum

21 January 2018

1 reference

Histone deacetylase inhibitors: molecular mechanisms of action

21 January 2018

1 reference

Identification and functional significance of genes regulated by structurally different histone deacetylase inhibitors

21 January 2018

1 reference

Molecular sequelae of histone deacetylase inhibition in human malignant B cells

21 January 2018

1 reference

Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation

21 January 2018

1 reference

CD44 in cancer progression: adhesion, migration and growth regulation

21 January 2018

1 reference

CD44 and its partners in metastasis

21 January 2018

1 reference

Hyaluronan-CD44 interaction activates stem cell marker Nanog, Stat-3-mediated MDR1 gene expression, and ankyrin-regulated multidrug efflux in breast and ovarian tumor cells

21 January 2018

1 reference

SP analysis may be used to identify cancer stem cell populations

21 January 2018

1 reference

Side population cells in human cancers

21 January 2018

1 reference

Histone modifications at the ABCG2 promoter following treatment with histone deacetylase inhibitor mirror those in multidrug-resistant cells

21 January 2018

1 reference

The epithelial-mesenchymal transition generates cells with properties of stem cells

21 January 2018

1 reference

Generation of breast cancer stem cells through epithelial-mesenchymal transition

21 January 2018

1 reference

Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cells

21 January 2018

1 reference

Side population of pancreatic cancer cells predominates in TGF-beta-mediated epithelial to mesenchymal transition and invasion.

21 January 2018

1 reference

Evidence for epithelial-mesenchymal transition in cancer stem cells of head and neck squamous cell carcinoma

21 January 2018

1 reference

HDAC inhibitor vorinostat enhances the antitumor effect of gefitinib in squamous cell carcinoma of head and neck by modulating ErbB receptor expression and reverting EMT.

21 January 2018

1 reference

Inhibition of histone deacetylase activity suppresses epithelial-to-mesenchymal transition induced by TGF-beta1 in human renal epithelial cells

21 January 2018

1 reference

Histone deacetylase inhibitors induce epithelial-to-mesenchymal transition in prostate cancer cells

21 January 2018

1 reference

Studies using an in vitro model show evidence of involvement of epithelial-mesenchymal transition of human endometrial epithelial cells in human embryo implantation

21 January 2018

1 reference

Phase I study of an oral histone deacetylase inhibitor, suberoylanilide hydroxamic acid, in patients with advanced cancer

21 January 2018

1 reference

Phase II trial of the histone deacetylase inhibitor vorinostat (Zolinza, suberoylanilide hydroxamic acid, SAHA) in patients with recurrent and/or metastatic head and neck cancer

21 January 2018

1 reference

Identification of a cancer stem cell in human brain tumors

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23992541

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Gene expression profiling of multiple histone deacetylase (HDAC) inhibitors: defining a common gene set produced by HDAC inhibition in T24 and MDA carcinoma cell lines

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23992541

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1111/CAS.12271

1 reference

9 September 2017

1 reference